Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.
about
Primary treatment of Crohn’s disease: combined antibiotics taking center stageIn vivo activities of newer rifamycin analogs against Mycobacterium avium infectionActivities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesLiposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige miceIn vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige miceEnhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige miceActivity of amikacin against Mycobacterium avium complex under simulated in vivo conditionsClarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige miceEffectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelActivity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infectionComparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexAnticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cellsHow effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.
P2860
Q22241483-DC605230-3C80-4FB5-B514-C509672549F9Q28322002-06B84804-C129-4741-8E28-C93E63C5795AQ28330701-A9A1C254-335D-4C59-889C-D99655432904Q28359692-6DEF79C9-1C42-46A4-AACA-782F01E98831Q28359886-79378BC5-8F09-4FEA-8B3D-F62C89BC760FQ28361166-60301DD9-FE55-474D-A58C-1F113DF206B1Q28361539-98B9AAAB-C638-402D-A8ED-D9301CC4C91FQ28368056-E1BBFC53-10FA-4C84-91FE-A2F5267A1D1AQ28368450-F5F5CFDF-7DF8-439D-AA48-10AF4F6ECBFDQ28369155-C3079C62-88BF-40D5-8747-D8E658277A70Q28369712-9115237B-7DF7-47A2-8DA4-C0C3510E7AB4Q28379178-10DF712C-B9C3-4CA6-B7AE-062EFFC2C5BDQ28379180-67BAFC60-9173-4DA4-A87C-9CEF31E03A50Q33745057-6C86C754-981A-46D9-AF1F-A9E508655903Q35112491-1FA773C1-F04B-46EB-94CB-6D33185DD6E8Q35112519-EED21D4F-3A22-4520-BF03-7AAF81F0D0C2
P2860
Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Activity of rifabutin alone or ...... ium intracellulare infections.
@en
Activity of rifabutin alone or ...... ium intracellulare infections.
@nl
type
label
Activity of rifabutin alone or ...... ium intracellulare infections.
@en
Activity of rifabutin alone or ...... ium intracellulare infections.
@nl
prefLabel
Activity of rifabutin alone or ...... ium intracellulare infections.
@en
Activity of rifabutin alone or ...... ium intracellulare infections.
@nl
P2093
P356
P1476
Activity of rifabutin alone or ...... ium intracellulare infections.
@en
P2093
Gangadharam PR
Perumal VK
P304
P356
10.1164/AJRCCM/136.2.329
P577
1987-08-01T00:00:00Z